Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

884.54
+24.812.89%
Post-market: 887.402.86+0.32%19:59 EDT
Volume:3.40M
Turnover:2.97B
Market Cap:838.53B
PE:75.54
High:885.58
Open:859.66
Low:851.07
Close:859.73
Loading ...

Amgen Rises Almost 22% YTD: Should You Buy, Hold or Sell the Stock?

Zacks
·
18 Mar

Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Zepbound(R)

ACCESS Newswire
·
18 Mar

Jim Cramer Says Eli Lilly And Co (LLY) Sellers Are ‘Uninformed’

Insider Monkey
·
18 Mar

Redburn Atlantic Adjusts Price Target on Eli Lilly and Company to $800 From $700, Keeps Neutral Rating

MT Newswires Live
·
18 Mar

Eli Lilly & Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Mar

NVO vs. LLY: Which Stock Is the Better Value Option?

Zacks
·
17 Mar

Is Eli Lilly and Company (LLY) the Best Quality Stock to Invest in Now?

Insider Monkey
·
15 Mar

Eli Lilly (NYSE:LLY) Sees 1.59% Rise As Jaypirca Secures Positive EU Opinion

Simply Wall St.
·
15 Mar

3 Healthcare Stocks with Exciting Potential

StockStory
·
14 Mar

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

Quartz
·
14 Mar

How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma

Zacks
·
13 Mar

Eli Lilly (NYSE:LLY) Advances Alopecia Study Results Amid 4% Share Price Rise

Simply Wall St.
·
12 Mar

Is Eli Lilly and Company (LLY) the Best Low Risk Stock to Buy In 2025?

Insider Monkey
·
12 Mar

Eli Lilly & Co: Promising CagriSema Performance Justifies Buy Rating Despite Tolerability Concerns

TIPRANKS
·
11 Mar

Morgan Stanley says REDEFINE-2 misses opportunity to differentiate in diabetes

TipRanks
·
11 Mar

Eli Lilly Rises 7.5% YTD: Time to Buy, Sell or Hold the Stock?

Zacks
·
11 Mar

Eli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss

Benzinga
·
11 Mar

Why Eli Lilly Stock Flopped Today

Motley Fool
·
11 Mar

Eli Lilly's first weight-loss pill could expand access to GLP-1s around the globe, executive says

Quartz
·
11 Mar

Rpt-Lilly Exec Says Co Expects Negotiations With Some Insurers for Coverage of Zepbound in Sleep Apnea in the Second Half of the Year- Leerink Conference

THOMSON REUTERS
·
10 Mar